Serabelisib Uses, Dosage, Side Effects and more
Serabelisib is under investigation in clinical trial NCT02625259 (A Study to Evaluate the Relative Bioavailability, Effect of Food, and Gastric Potential Hydrogen (pH) Modification on the Pharmacokinetics of TAK-117 (MLN1117) in Healthy Participants).
| Trade Name | Serabelisib |
| Generic | Serabelisib |
| Serabelisib Other Names | Serabelisib |
| Type | |
| Formula | C19H17N5O3 |
| Weight | Average: 363.377 Monoisotopic: 363.133139427 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
